首页 > 最新文献

Journal of General Internal Medicine最新文献

英文 中文
The Little Voice in My Head. 我脑海中的小声音
IF 4.3 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-11-01 Epub Date: 2024-07-09 DOI: 10.1007/s11606-024-08920-6
Jennifer A Ross
{"title":"The Little Voice in My Head.","authors":"Jennifer A Ross","doi":"10.1007/s11606-024-08920-6","DOIUrl":"10.1007/s11606-024-08920-6","url":null,"abstract":"","PeriodicalId":15860,"journal":{"name":"Journal of General Internal Medicine","volume":" ","pages":"2864-2865"},"PeriodicalIF":4.3,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11535089/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141558922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Workplace Violence Against Primary Care Clinicians: A Narrative Review. 针对初级保健临床医生的工作场所暴力:叙述性综述。
IF 4.3 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-11-01 Epub Date: 2024-07-08 DOI: 10.1007/s11606-024-08850-3
Nicholas D Tyau, Kristin A Swedish, Hector R Perez

Workplace violence (WPV) is a commonly reported occupational hazard in healthcare and its prevalence is increasing. WPV occurs in all types of practice settings, but little is known about WPV in primary care settings in the United States (US). Because primary care practice settings differ from the inpatient settings, further examination of WPV in primary care is warranted. Our objective was to summarize the available literature highlight important gaps. We conducted a search using Pubmed and OVID for US studies of WPV in US-based adult primary care practices. Studies including only pediatric populations were excluded. Due to the lack of available literature conducted in US primary care settings, we expanded our search to include international studies. We identified 70 studies of which 5 were US based. Due to the lack of significant numbers of US-based studies, we opted to conduct a narrative review of all available studies. The evidence shows that WPV is a common occurrence in primary care settings in many countries and that the majority of primary care clinicians have experienced at least some form of non-physical violence in their careers. Most of the studies conducted were cross-sectional in design and reported on both non-physical and physical forms of WPV. There was not a consistent trend between genders in experiencing the major forms of WPV, but women were consistently more likely to be subjected to sexual harassment. Potential root causes for WPV could generally be categorized as patient-level, clinician-level, clinical encounter specific, and operational root causes. While most WPV was found to be non-physical, it still had significant emotional and job-related impacts on clinicians. These troubling results highlight the need for further studies to be conducted in the US.

据报道,工作场所暴力(WPV)是医疗行业中常见的一种职业危害,其发生率正在不断上升。工作场所暴力发生在所有类型的医疗机构中,但人们对美国初级医疗机构中的工作场所暴力知之甚少。由于初级医疗机构与住院医疗机构不同,因此有必要对初级医疗机构中的 WPV 进行进一步研究。我们的目标是总结现有的文献,突出重要的空白点。我们使用 Pubmed 和 OVID 对美国成人初级保健实践中的 WPV 研究进行了搜索。仅包括儿科人群的研究被排除在外。由于缺乏在美国初级医疗机构进行的可用文献,我们将搜索范围扩大到国际研究。我们共发现了 70 项研究,其中 5 项来自美国。由于缺乏大量基于美国的研究,我们选择对所有可用研究进行叙述性综述。有证据表明,WPV 在许多国家的基层医疗机构中都很常见,大多数基层医疗机构的临床医生在其职业生涯中至少经历过某种形式的非身体暴力。大多数研究都是横断面设计,并报告了非身体和身体形式的 WPV。在遭受主要形式的 WPV 方面,不同性别之间的趋势并不一致,但女性遭受性骚扰的可能性一直较高。WPV 的潜在根本原因一般可分为患者层面、临床医生层面、特定临床情况和操作层面的根本原因。虽然大多数 WPV 被发现是非身体性的,但它仍然对临床医生的情绪和工作产生了重大影响。这些令人担忧的结果凸显了在美国开展进一步研究的必要性。
{"title":"Workplace Violence Against Primary Care Clinicians: A Narrative Review.","authors":"Nicholas D Tyau, Kristin A Swedish, Hector R Perez","doi":"10.1007/s11606-024-08850-3","DOIUrl":"10.1007/s11606-024-08850-3","url":null,"abstract":"<p><p>Workplace violence (WPV) is a commonly reported occupational hazard in healthcare and its prevalence is increasing. WPV occurs in all types of practice settings, but little is known about WPV in primary care settings in the United States (US). Because primary care practice settings differ from the inpatient settings, further examination of WPV in primary care is warranted. Our objective was to summarize the available literature highlight important gaps. We conducted a search using Pubmed and OVID for US studies of WPV in US-based adult primary care practices. Studies including only pediatric populations were excluded. Due to the lack of available literature conducted in US primary care settings, we expanded our search to include international studies. We identified 70 studies of which 5 were US based. Due to the lack of significant numbers of US-based studies, we opted to conduct a narrative review of all available studies. The evidence shows that WPV is a common occurrence in primary care settings in many countries and that the majority of primary care clinicians have experienced at least some form of non-physical violence in their careers. Most of the studies conducted were cross-sectional in design and reported on both non-physical and physical forms of WPV. There was not a consistent trend between genders in experiencing the major forms of WPV, but women were consistently more likely to be subjected to sexual harassment. Potential root causes for WPV could generally be categorized as patient-level, clinician-level, clinical encounter specific, and operational root causes. While most WPV was found to be non-physical, it still had significant emotional and job-related impacts on clinicians. These troubling results highlight the need for further studies to be conducted in the US.</p>","PeriodicalId":15860,"journal":{"name":"Journal of General Internal Medicine","volume":" ","pages":"2806-2828"},"PeriodicalIF":4.3,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11534957/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141558924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the Telephone Call Experience of Patients with Non-English Language Preference in Primary Care vs. Specialty. 探索非英语语言偏好患者在初级医疗与专科医疗中的电话呼叫体验。
IF 4.3 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-11-01 Epub Date: 2024-07-03 DOI: 10.1007/s11606-024-08895-4
Miguel Linares, Emily Linares, Jorge A Rodriguez

Background: Latine people, comprising 18.5% of the US population, constitute the largest ethnic minority group, with nearly one-third self-identifying as having non-English language preference (NELP). Despite the importance of the telephone in health care access, there is limited understanding of how NELP patients navigate telephone calls with primary and specialty care clinics.

Objective: This qualitative study aims to capture how Spanish speakers with NELP characterize their telephone call experiences with primary and specialty care clinics.

Design: Semi-structured interviews were conducted with 24 Spanish-speaking participants from primary care clinics with a sizeable proportion of patients who prefer to communicate in a language other than English at an urban academic medical center in Boston, MA.

Participants: Participants were selected from primary care clinics that were well-equipped to serve Spanish-speaking patients. A total of 24 Spanish-speaking patients with NELP, mainly women (83%), with a mean age of 55.8 years, participated. They represented diverse countries of origin, with an average length of time in the USA of 21.7 years.

Approach: Interview questions prompted participants to describe their telephone call experiences with front desk staff, with attention to interpreter availability, ancillary assistance, health outcomes stemming from a lack of language services, and emotional consequences of language discordance on calls.

Key results: Patients perceived primary care clinics as providing familiarity and language concordance during telephone interactions, contrasting with specialty care clinics, seen as sources of monolingual English communication. Participants utilized various strategies, such as requesting interpreters, using concise English phrases, or seeking assistance from acquaintances, relatives, or primary care clinic staff, to mitigate language barriers.

Conclusions: The findings underscore significant challenges faced by Spanish-speaking patients with NELP in ambulatory specialty care telephone calls. The study emphasizes the importance of creating inclusive multilingual telephone environments, standardizing interpreter access, and reflecting the diversity of the communities served.

背景:拉丁裔美国人占美国人口的 18.5%,是最大的少数民族群体,其中近三分之一的人自认为有非英语语言偏好 (NELP)。尽管电话在获取医疗保健服务方面非常重要,但人们对 NELP 患者如何与初级和专科诊所进行电话沟通的了解却很有限:本定性研究旨在了解讲西班牙语的 NELP 患者如何描述他们与初级和专科诊所的电话通话经历:在马萨诸塞州波士顿市的一个城市学术医疗中心,对 24 名来自初级保健诊所的西班牙语参与者进行了半结构化访谈,这些诊所有相当一部分患者喜欢用英语以外的语言进行交流:参与者是从为西班牙语患者提供服务的初级保健诊所中挑选出来的。共有 24 名讲西班牙语的 NELP 患者参加了此次调查,其中以女性为主(83%),平均年龄为 55.8 岁。他们来自不同的国家,在美国的平均居住时间为 21.7 年:访谈问题促使参与者描述他们与前台工作人员通话的经历,并关注是否有翻译人员、辅助援助、因缺乏语言服务而导致的健康后果,以及通话中语言不一致造成的情绪后果:主要结果:患者认为初级保健诊所在电话互动中提供熟悉和语言一致的服务,这与专科诊所形成鲜明对比,后者被视为单语英语交流的来源。参与者采用了各种策略,如请求翻译、使用简洁的英语短语或寻求熟人、亲属或初级保健诊所工作人员的帮助,以减轻语言障碍:研究结果强调了讲西班牙语的 NELP 患者在非住院专科护理电话中面临的重大挑战。该研究强调了创建包容性多语言电话环境、实现口译服务标准化以及反映服务社区多样性的重要性。
{"title":"Exploring the Telephone Call Experience of Patients with Non-English Language Preference in Primary Care vs. Specialty.","authors":"Miguel Linares, Emily Linares, Jorge A Rodriguez","doi":"10.1007/s11606-024-08895-4","DOIUrl":"10.1007/s11606-024-08895-4","url":null,"abstract":"<p><strong>Background: </strong>Latine people, comprising 18.5% of the US population, constitute the largest ethnic minority group, with nearly one-third self-identifying as having non-English language preference (NELP). Despite the importance of the telephone in health care access, there is limited understanding of how NELP patients navigate telephone calls with primary and specialty care clinics.</p><p><strong>Objective: </strong>This qualitative study aims to capture how Spanish speakers with NELP characterize their telephone call experiences with primary and specialty care clinics.</p><p><strong>Design: </strong>Semi-structured interviews were conducted with 24 Spanish-speaking participants from primary care clinics with a sizeable proportion of patients who prefer to communicate in a language other than English at an urban academic medical center in Boston, MA.</p><p><strong>Participants: </strong>Participants were selected from primary care clinics that were well-equipped to serve Spanish-speaking patients. A total of 24 Spanish-speaking patients with NELP, mainly women (83%), with a mean age of 55.8 years, participated. They represented diverse countries of origin, with an average length of time in the USA of 21.7 years.</p><p><strong>Approach: </strong>Interview questions prompted participants to describe their telephone call experiences with front desk staff, with attention to interpreter availability, ancillary assistance, health outcomes stemming from a lack of language services, and emotional consequences of language discordance on calls.</p><p><strong>Key results: </strong>Patients perceived primary care clinics as providing familiarity and language concordance during telephone interactions, contrasting with specialty care clinics, seen as sources of monolingual English communication. Participants utilized various strategies, such as requesting interpreters, using concise English phrases, or seeking assistance from acquaintances, relatives, or primary care clinic staff, to mitigate language barriers.</p><p><strong>Conclusions: </strong>The findings underscore significant challenges faced by Spanish-speaking patients with NELP in ambulatory specialty care telephone calls. The study emphasizes the importance of creating inclusive multilingual telephone environments, standardizing interpreter access, and reflecting the diversity of the communities served.</p>","PeriodicalId":15860,"journal":{"name":"Journal of General Internal Medicine","volume":" ","pages":"2724-2731"},"PeriodicalIF":4.3,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11534924/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141498177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative Safety Analysis of Nabilone Versus Opioids: A Population-Based Cohort Study. 纳比龙与阿片类药物的安全性对比分析:基于人群的队列研究。
IF 4.3 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-11-01 Epub Date: 2024-08-14 DOI: 10.1007/s11606-024-08978-2
Nicholas T Vozoris, Longdi Fu, Peter C Austin, Anne L Stephenson, Sudeep S Gill, Chung-Wai Chow, Clodagh M Ryan, Teresa To

Background: Some have advocated that nabilone be used rather than opioids to manage chronic, noncancer pain, since the former drug may have a better safety profile.

Objective: We compared the safety of incident nabilone use relative to incident opioid use with respect to multiple clinically important outcomes.

Design: A population-based, retrospective cohort study.

Setting: Province of Ontario, Canada.

Participants: Persons aged 12 years and older, diagnosed with a musculoskeletal condition within the past 3 years prior to the index date.

Exposures: Incident nabilone use, with incident opioid use serving as the reference group.

Measurements: Within 3 months following the index date, we separately evaluated for pneumonia, motor vehicle accidents, falls or fractures, mental and behavioral disorder due to psychoactive substance use, and all-cause mortality.

Results: A total of 18,863 incident nabilone users were propensity score matched to an equal number of opioid users. In the overall matched analysis, incident nabilone users vs. incident opioid users had significantly lower rates of pneumonia (hazard ratio [HR] 0.78, 95% CI 0.63-0.96), falls or fractures (HR 0.56, 95% CI 0.50-0.64), and all-cause mortality (HR 0.79, 95% CI 0.65-0.95), but significantly higher rate of mental or behavioral disorder (HR 2.23, 95% CI 1.45-3.43). There was no significant difference between groups with respect to rate of motor vehicle accidents.

Limitations: Unmeasured confounding may have influenced results.

Conclusions: While usage of nabilone relative to opioids was associated with reduced rates of pneumonia, falls or fractures, and all-cause mortality, it was simultaneously associated with an increased rate of adverse mental health outcomes. This picture of mixed safety results raises concerns with the policy approach of broadly substituting use of opioids with nabilone.

Funding source: Ontario Ministry of Health.

背景:有人主张使用纳比隆而不是阿片类药物来治疗慢性非癌性疼痛,因为前者的安全性可能更好:一些人主张使用纳比隆而不是阿片类药物来治疗慢性非癌症疼痛,因为前者可能具有更好的安全性:我们比较了使用纳比隆与使用阿片类药物在多个临床重要结果方面的安全性:设计:基于人群的回顾性队列研究:地点:加拿大安大略省:参与者:年龄在 12 岁及以上,在指数日期前的过去 3 年内被诊断出患有肌肉骨骼疾病的人:暴露:使用纳比隆的事件,以使用阿片类药物的事件作为参照组:在指数日期后的 3 个月内,我们分别评估了肺炎、机动车事故、跌倒或骨折、使用精神活性物质导致的精神和行为障碍以及全因死亡率:共有 18,863 名纳比龙使用者与同等数量的阿片类药物使用者进行了倾向评分匹配。在总体匹配分析中,纳比隆使用者与阿片类药物使用者相比,肺炎(危险比 [HR]0.78,95% CI 0.63-0.96)、跌倒或骨折(HR 0.56,95% CI 0.50-0.64)和全因死亡率(HR 0.79,95% CI 0.65-0.95)明显较低,但精神或行为障碍(HR 2.23,95% CI 1.45-3.43)明显较高。在机动车事故发生率方面,组间没有明显差异:未测量的混杂因素可能会影响结果:虽然相对于阿片类药物,使用纳比龙可降低肺炎、跌倒或骨折以及全因死亡率,但同时也会增加不良精神健康后果的发生率。这种好坏参半的安全结果引起了人们对广泛使用纳比龙替代阿片类药物的政策方针的担忧:资金来源:安大略省卫生部。
{"title":"Comparative Safety Analysis of Nabilone Versus Opioids: A Population-Based Cohort Study.","authors":"Nicholas T Vozoris, Longdi Fu, Peter C Austin, Anne L Stephenson, Sudeep S Gill, Chung-Wai Chow, Clodagh M Ryan, Teresa To","doi":"10.1007/s11606-024-08978-2","DOIUrl":"10.1007/s11606-024-08978-2","url":null,"abstract":"<p><strong>Background: </strong>Some have advocated that nabilone be used rather than opioids to manage chronic, noncancer pain, since the former drug may have a better safety profile.</p><p><strong>Objective: </strong>We compared the safety of incident nabilone use relative to incident opioid use with respect to multiple clinically important outcomes.</p><p><strong>Design: </strong>A population-based, retrospective cohort study.</p><p><strong>Setting: </strong>Province of Ontario, Canada.</p><p><strong>Participants: </strong>Persons aged 12 years and older, diagnosed with a musculoskeletal condition within the past 3 years prior to the index date.</p><p><strong>Exposures: </strong>Incident nabilone use, with incident opioid use serving as the reference group.</p><p><strong>Measurements: </strong>Within 3 months following the index date, we separately evaluated for pneumonia, motor vehicle accidents, falls or fractures, mental and behavioral disorder due to psychoactive substance use, and all-cause mortality.</p><p><strong>Results: </strong>A total of 18,863 incident nabilone users were propensity score matched to an equal number of opioid users. In the overall matched analysis, incident nabilone users vs. incident opioid users had significantly lower rates of pneumonia (hazard ratio [HR] 0.78, 95% CI 0.63-0.96), falls or fractures (HR 0.56, 95% CI 0.50-0.64), and all-cause mortality (HR 0.79, 95% CI 0.65-0.95), but significantly higher rate of mental or behavioral disorder (HR 2.23, 95% CI 1.45-3.43). There was no significant difference between groups with respect to rate of motor vehicle accidents.</p><p><strong>Limitations: </strong>Unmeasured confounding may have influenced results.</p><p><strong>Conclusions: </strong>While usage of nabilone relative to opioids was associated with reduced rates of pneumonia, falls or fractures, and all-cause mortality, it was simultaneously associated with an increased rate of adverse mental health outcomes. This picture of mixed safety results raises concerns with the policy approach of broadly substituting use of opioids with nabilone.</p><p><strong>Funding source: </strong>Ontario Ministry of Health.</p>","PeriodicalId":15860,"journal":{"name":"Journal of General Internal Medicine","volume":" ","pages":"2716-2723"},"PeriodicalIF":4.3,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11535096/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141975822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Professional Pearls. 专业珍珠
IF 4.3 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-11-01 Epub Date: 2024-09-09 DOI: 10.1007/s11606-024-08994-2
Eleanor R Menzin
{"title":"Professional Pearls.","authors":"Eleanor R Menzin","doi":"10.1007/s11606-024-08994-2","DOIUrl":"10.1007/s11606-024-08994-2","url":null,"abstract":"","PeriodicalId":15860,"journal":{"name":"Journal of General Internal Medicine","volume":" ","pages":"2862-2863"},"PeriodicalIF":4.3,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11534904/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142154307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rising to the Challenge of Rare Diagnoses. 迎接罕见诊断的挑战。
IF 4.3 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-11-01 DOI: 10.1007/s11606-024-09086-x
Kevin Venus, Janice L Kwan, David W Frost

Patients with rare conditions often experience substantial delays between presentation and diagnosis, and some remain undiagnosed. In this Perspective, we outline the many challenges in diagnosing rare conditions in the modern clinical context. We review relevant concepts of diagnostic reasoning as they relate to rare conditions. We present solutions currently available for clinicians to mitigate some of these problems, including facilitating deliberate reflection, utilizing a diagnostic management team, and optimizing diagnostic calibration. Finally, we speculate how technology, such as chatbots and decision support tools enhanced by artificial intelligence, may augment a clinician's ability to diagnose rare conditions in a timely and accurate manner without excessive resource use.

罕见疾病患者从就诊到确诊之间往往会出现严重的延误,有些患者甚至仍未确诊。在本视角中,我们概述了在现代临床环境中诊断罕见病症所面临的诸多挑战。我们回顾了与罕见病相关的诊断推理概念。我们介绍了临床医生目前可用于缓解其中一些问题的解决方案,包括促进深思熟虑、利用诊断管理团队和优化诊断校准。最后,我们推测聊天机器人和人工智能决策支持工具等技术如何在不过度使用资源的情况下增强临床医生及时准确诊断罕见病症的能力。
{"title":"Rising to the Challenge of Rare Diagnoses.","authors":"Kevin Venus, Janice L Kwan, David W Frost","doi":"10.1007/s11606-024-09086-x","DOIUrl":"https://doi.org/10.1007/s11606-024-09086-x","url":null,"abstract":"<p><p>Patients with rare conditions often experience substantial delays between presentation and diagnosis, and some remain undiagnosed. In this Perspective, we outline the many challenges in diagnosing rare conditions in the modern clinical context. We review relevant concepts of diagnostic reasoning as they relate to rare conditions. We present solutions currently available for clinicians to mitigate some of these problems, including facilitating deliberate reflection, utilizing a diagnostic management team, and optimizing diagnostic calibration. Finally, we speculate how technology, such as chatbots and decision support tools enhanced by artificial intelligence, may augment a clinician's ability to diagnose rare conditions in a timely and accurate manner without excessive resource use.</p>","PeriodicalId":15860,"journal":{"name":"Journal of General Internal Medicine","volume":" ","pages":""},"PeriodicalIF":4.3,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142562480","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Receipt of Gender-Affirming Surgeries Among Transgender and Gender Diverse Veterans. 变性和不同性别退伍军人接受性别确认手术的情况。
IF 4.3 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-11-01 Epub Date: 2024-07-26 DOI: 10.1007/s11606-024-08917-1
Alyson J Littman, Amy Jeon, Carolyn L Fort, Krista Dashtestani, Anna Korpak, Michael R Kauth, Jillian C Shipherd, Guneet K Jasuja, Hill L Wolfe, Paula M Neira, Josie Caballero, Sady Garcia, Cassandra Williamson, Benjamin Collongues, Tracy L Simpson

Background: Gender-affirming surgery (GAS) can be an important part of comprehensive care for transgender and gender diverse (TGD) individuals, but this care is not provided by the Department of Veterans Affairs (VA) because of an exclusion in the medical benefits package.

Objective: To describe the receipt of GAS by veterans and assess the associations between key sociodemographic characteristics and receipt of chest ("top") and genital ("bottom") surgeries.

Design: Cross-sectional national survey (the GendeR Affirming Care Evaluation (GRACE)), among TGD Veterans conducted between September 2022 and July 2023.

Participants: A total of 6653 Veterans (54% response rate) completed the survey.

Main measures: Self-reported "top" and "bottom" GAS were key outcomes. Covariates included gender identity, sex assigned at birth, age, race, ethnicity, income, employment status, education, relationship status, sexual orientation, and geographic region.

Key results: Among all respondents, 39% had ≥ 1 GAS. Among the 4430 veterans interested in top surgery, 38% received it; 23% of 3911 veterans interested in bottom surgery had received it. In multivariable models, older age (50 + vs. 18-39) was associated with higher receipt of top and bottom surgery while nonbinary gender identity (vs. binary gender identity), lower household income (< $50,000 vs. > $75,000), less education (less than a college graduate vs. Master's degree or more), sexual orientations other than heterosexual, and residing in a region other than the Pacific were associated with lower receipt of top and bottom surgery. Individuals assigned male (vs. assigned female) at birth had lower receipt of top surgery and higher receipt of bottom surgery.

Conclusions: GAS receipt was low and there were important disparities by gender, sex, income, education, sexual orientation, and region. By removing the exclusion to providing GAS, VA could reduce barriers to accessing GAS and decrease disparities among TGD veterans.

背景:性别确认手术(GAS)可以成为变性者和性别多元化者(TGD)综合护理的重要组成部分,但由于医疗福利包中的一项排除条款,退伍军人事务部(VA)并未提供这种护理:描述退伍军人接受 GAS 的情况,评估主要社会人口特征与接受胸部("上")和生殖器("下")手术之间的关联:设计:在 2022 年 9 月至 2023 年 7 月期间对 TGD 退伍军人进行横断面全国调查(GendeR Affirming Care Evaluation,GRACE):共有 6653 名退伍军人(回复率为 54%)完成了调查:自我报告的 "最高 "和 "最低 "GAS是主要结果。协变量包括性别认同、出生时性别、年龄、种族、民族、收入、就业状况、教育程度、关系状况、性取向和地理区域:在所有受访者中,39% 的人≥ 1 次 GAS。在 4430 名对上部手术感兴趣的退伍军人中,38% 接受了手术;在 3911 名对下部手术感兴趣的退伍军人中,23% 接受了手术。在多变量模型中,年龄越大(50 岁以上 vs. 18-39 岁),接受上部和下部手术的比例越高,而非二元性别认同(vs. 二元性别认同)、家庭收入较低(75,000 美元)、教育程度较低(大学毕业以下 vs. 硕士学位或以上)、性取向非异性恋以及居住在太平洋地区以外的其他地区,则与接受上部和下部手术的比例较低有关。出生时被指定为男性(与被指定为女性)的人接受上部手术的比例较低,接受下部手术的比例较高:结论:接受 GAS 的比例较低,而且不同性别、性别、收入、教育程度、性取向和地区之间存在很大差异。通过取消提供 GAS 的限制,退伍军人事务部可以减少获得 GAS 的障碍,并减少 TGD 退伍军人之间的差异。
{"title":"Receipt of Gender-Affirming Surgeries Among Transgender and Gender Diverse Veterans.","authors":"Alyson J Littman, Amy Jeon, Carolyn L Fort, Krista Dashtestani, Anna Korpak, Michael R Kauth, Jillian C Shipherd, Guneet K Jasuja, Hill L Wolfe, Paula M Neira, Josie Caballero, Sady Garcia, Cassandra Williamson, Benjamin Collongues, Tracy L Simpson","doi":"10.1007/s11606-024-08917-1","DOIUrl":"10.1007/s11606-024-08917-1","url":null,"abstract":"<p><strong>Background: </strong>Gender-affirming surgery (GAS) can be an important part of comprehensive care for transgender and gender diverse (TGD) individuals, but this care is not provided by the Department of Veterans Affairs (VA) because of an exclusion in the medical benefits package.</p><p><strong>Objective: </strong>To describe the receipt of GAS by veterans and assess the associations between key sociodemographic characteristics and receipt of chest (\"top\") and genital (\"bottom\") surgeries.</p><p><strong>Design: </strong>Cross-sectional national survey (the GendeR Affirming Care Evaluation (GRACE)), among TGD Veterans conducted between September 2022 and July 2023.</p><p><strong>Participants: </strong>A total of 6653 Veterans (54% response rate) completed the survey.</p><p><strong>Main measures: </strong>Self-reported \"top\" and \"bottom\" GAS were key outcomes. Covariates included gender identity, sex assigned at birth, age, race, ethnicity, income, employment status, education, relationship status, sexual orientation, and geographic region.</p><p><strong>Key results: </strong>Among all respondents, 39% had ≥ 1 GAS. Among the 4430 veterans interested in top surgery, 38% received it; 23% of 3911 veterans interested in bottom surgery had received it. In multivariable models, older age (50 + vs. 18-39) was associated with higher receipt of top and bottom surgery while nonbinary gender identity (vs. binary gender identity), lower household income (< $50,000 vs. > $75,000), less education (less than a college graduate vs. Master's degree or more), sexual orientations other than heterosexual, and residing in a region other than the Pacific were associated with lower receipt of top and bottom surgery. Individuals assigned male (vs. assigned female) at birth had lower receipt of top surgery and higher receipt of bottom surgery.</p><p><strong>Conclusions: </strong>GAS receipt was low and there were important disparities by gender, sex, income, education, sexual orientation, and region. By removing the exclusion to providing GAS, VA could reduce barriers to accessing GAS and decrease disparities among TGD veterans.</p>","PeriodicalId":15860,"journal":{"name":"Journal of General Internal Medicine","volume":" ","pages":"3042-3051"},"PeriodicalIF":4.3,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11576719/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141766235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Respiratory Syncytial Virus (RSV) Vaccine Uptake Among Older Adults: a Population-Based Study of Massachusetts Towns. 老年人的呼吸道合胞病毒 (RSV) 疫苗接种率:马萨诸塞州城镇的人口研究。
IF 4.3 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-11-01 Epub Date: 2024-08-16 DOI: 10.1007/s11606-024-08999-x
Adam Gaffney, David U Himmelstein, Danny McCormick, Steffie Woolhandler
{"title":"Respiratory Syncytial Virus (RSV) Vaccine Uptake Among Older Adults: a Population-Based Study of Massachusetts Towns.","authors":"Adam Gaffney, David U Himmelstein, Danny McCormick, Steffie Woolhandler","doi":"10.1007/s11606-024-08999-x","DOIUrl":"10.1007/s11606-024-08999-x","url":null,"abstract":"","PeriodicalId":15860,"journal":{"name":"Journal of General Internal Medicine","volume":" ","pages":"3096-3098"},"PeriodicalIF":4.3,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11576673/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141995846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vitamin D Supplementation and the Incidence of Fractures in the Elderly Healthy Population: A Meta-analysis of Randomized Controlled Trials. 维生素 D 补充剂与老年健康人群骨折发生率:随机对照试验的元分析》。
IF 4.3 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-11-01 Epub Date: 2024-07-12 DOI: 10.1007/s11606-024-08933-1
Mariana de Moura de Souza, Rachel Louise Moraes Dantas, Vitor Leão Durães, Maria Luiza Rodrigues Defante, Thiago Bosco Mendes

Introduction: Although a well-established component of bone metabolism, the efficacy and safety of vitamin D supplementation for the prevention of fractures in elderly healthy individuals is still unclear.

Purpose: To perform a meta-analysis comparing vitamin D supplementation with placebo and its contributions on fracture incidence.

Methods: This meta-analysis was registered in the International Prospective Register of Systematic Reviews (PROSPERO), under protocol CRD42023484979. We systematically searched PubMed, Embase, and Cochrane Central databases from inception to November 2023 for randomized controlled trials (RCTs) comparing vitamin D supplementation versus placebo in individuals with 60 years of age or more and without bone related medical conditions such as cancer and osteoporosis.

Results: Seven RCTs with 71,899 patients were included, of whom 36,822 (51.2%) were women. There was no significant difference in total fracture incidence (RR 1.03; 95% CI 0.93-1.14; p = 0.56; I2 = 58%) between groups or subgroups. However, women had an increased risk for hip fractures (164 vs. 121 events; RR 1.34; 95% CI 1.06-1.70; p = 0.01; I2 = 0%). There was no significant difference in non-vertebral fractures, osteoporotic fractures development, or falls (RR 1.02; 95% CI 0.94-1.12; p = 0.6; I2 = 47%; RR 0.97; 95% CI 0.87-1.08; p = 0.63; I2 = 0%; RR 1.01; 95% CI 0.97-1.04; p = 0.66; I2 = 55%, respectively).

Conclusion: Vitamin D supplementation does not reduce the total fracture development rate in the elderly healthy population, and it may increase the incidence of hip fractures among elderly healthy women. This finding suggests refraining from prescribing high intermittent doses of vitamin D, without calcium, to individuals aged 60 or older with unknown vitamin D serum concentration or osteoporosis status and inadequate calcium intake.

导言:维生素 D 是骨代谢的重要组成部分,但维生素 D 补充剂对预防健康老人骨折的有效性和安全性尚不明确:目的:进行一项荟萃分析,比较维生素 D 补充剂与安慰剂及其对骨折发生率的影响:该荟萃分析已在国际系统综述前瞻性注册中心(PROSPERO)注册,注册协议为 CRD42023484979。我们系统检索了 PubMed、Embase 和 Cochrane Central 数据库中从开始到 2023 年 11 月的随机对照试验 (RCT),这些试验比较了维生素 D 补充剂与安慰剂对 60 岁或以上、无癌症和骨质疏松症等骨骼相关疾病的作用:结果:共纳入了 7 项 RCT,71899 名患者,其中 36822 人(51.2%)为女性。不同组别或亚组间的总骨折发生率无明显差异(RR 1.03;95% CI 0.93-1.14;P = 0.56;I2 = 58%)。然而,女性发生髋部骨折的风险增加(164 例 vs. 121 例;RR 1.34;95% CI 1.06-1.70;p = 0.01;I2 = 0%)。在非椎体骨折、骨质疏松性骨折发生或跌倒方面没有明显差异(RR 1.02;95% CI 0.94-1.12;P = 0.6;I2 = 47%;RR 0.97;95% CI 0.87-1.08;P = 0.63;I2 = 0%;RR 1.01;95% CI 0.97-1.04;P = 0.66;I2 = 55%):结论:补充维生素 D 并不能降低健康老人的骨折发生率,反而会增加健康老人髋部骨折的发生率。这一研究结果表明,对于维生素 D 血清浓度或骨质疏松症状况不明且钙摄入不足的 60 岁及以上人群,应避免开具间歇性大剂量维生素 D 的处方而不补钙。
{"title":"Vitamin D Supplementation and the Incidence of Fractures in the Elderly Healthy Population: A Meta-analysis of Randomized Controlled Trials.","authors":"Mariana de Moura de Souza, Rachel Louise Moraes Dantas, Vitor Leão Durães, Maria Luiza Rodrigues Defante, Thiago Bosco Mendes","doi":"10.1007/s11606-024-08933-1","DOIUrl":"10.1007/s11606-024-08933-1","url":null,"abstract":"<p><strong>Introduction: </strong>Although a well-established component of bone metabolism, the efficacy and safety of vitamin D supplementation for the prevention of fractures in elderly healthy individuals is still unclear.</p><p><strong>Purpose: </strong>To perform a meta-analysis comparing vitamin D supplementation with placebo and its contributions on fracture incidence.</p><p><strong>Methods: </strong>This meta-analysis was registered in the International Prospective Register of Systematic Reviews (PROSPERO), under protocol CRD42023484979. We systematically searched PubMed, Embase, and Cochrane Central databases from inception to November 2023 for randomized controlled trials (RCTs) comparing vitamin D supplementation versus placebo in individuals with 60 years of age or more and without bone related medical conditions such as cancer and osteoporosis.</p><p><strong>Results: </strong>Seven RCTs with 71,899 patients were included, of whom 36,822 (51.2%) were women. There was no significant difference in total fracture incidence (RR 1.03; 95% CI 0.93-1.14; p = 0.56; I<sup>2</sup> = 58%) between groups or subgroups. However, women had an increased risk for hip fractures (164 vs. 121 events; RR 1.34; 95% CI 1.06-1.70; p = 0.01; I<sup>2</sup> = 0%). There was no significant difference in non-vertebral fractures, osteoporotic fractures development, or falls (RR 1.02; 95% CI 0.94-1.12; p = 0.6; I<sup>2</sup> = 47%; RR 0.97; 95% CI 0.87-1.08; p = 0.63; I<sup>2</sup> = 0%; RR 1.01; 95% CI 0.97-1.04; p = 0.66; I<sup>2</sup> = 55%, respectively).</p><p><strong>Conclusion: </strong>Vitamin D supplementation does not reduce the total fracture development rate in the elderly healthy population, and it may increase the incidence of hip fractures among elderly healthy women. This finding suggests refraining from prescribing high intermittent doses of vitamin D, without calcium, to individuals aged 60 or older with unknown vitamin D serum concentration or osteoporosis status and inadequate calcium intake.</p>","PeriodicalId":15860,"journal":{"name":"Journal of General Internal Medicine","volume":" ","pages":"2829-2836"},"PeriodicalIF":4.3,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11534935/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141600224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sex Disparities in Opioid Prescription and Administration on a Hospital Medicine Service. 医院内科阿片类药物处方和用药的性别差异。
IF 4.3 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-11-01 Epub Date: 2024-08-09 DOI: 10.1007/s11606-024-08814-7
Nancy Yang, Margaret C Fang, Aksharananda Rambachan

Introduction: Decisions to prescribe opioids to patients depend on many factors, including illness severity, pain assessment, and patient age, race, ethnicity, and gender. Gender and sex disparities have been documented in many healthcare settings, but are understudied in inpatient general medicine hospital settings.

Objective: We assessed for differences in opioid administration and prescription patterns by legal sex in adult patient hospitalizations from the general medicine service at a large urban academic center.

Designs, setting, and participants: This study included all adult patient hospitalizations discharged from the acute care inpatient general medicine services at the University of California, San Francisco (UCSF) Helen Diller Medical Center at Parnassus Heights from 1/1/2013 to 9/30/2021.

Main outcome and measures: The primary outcomes were (1) average daily inpatient opioids received and (2) days of opioids prescribed on discharge. For both outcomes, we first performed logistic regression to assess differences in whether or not any opioids were administered or prescribed. Then, we performed negative binomial regression to assess differences in the amount of opioids given. We also performed all analyses on a subgroup of hospitalizations with pain-related diagnoses.

Results: Our study cohort included 48,745 hospitalizations involving 27,777 patients. Of these, 24,398 (50.1%) hospitalizations were female patients and 24,347 (49.9%) were male. Controlling for demographic, clinical, and hospitalization-level variables, female patients were less likely to receive inpatient opioids compared to male patents (adjusted OR 0.87; 95% CI 0.82, 0.92) and received 27.5 fewer morphine milligram equivalents per day on average (95% CI - 39.0, - 16.0). When considering discharge opioids, no significant differences were found between sexes. In the subgroup analysis of pain-related diagnoses, female patients received fewer inpatient opioids.

Conclusions: Female patients were less likely to receive inpatient opioids and received fewer opioids when prescribed. Future work to promote equity should identify strategies to ensure all patients receive adequate pain management.

导言:给患者开阿片类药物的决定取决于很多因素,包括病情严重程度、疼痛评估、患者年龄、种族、民族和性别。性别和性别差异在许多医疗机构中都有记录,但在综合医院的住院病人中却鲜有研究:我们评估了一家大型城市学术中心普通内科住院成人患者的阿片类药物用药和处方模式在法定性别上的差异:本研究包括加利福尼亚大学旧金山分校(UCSF)帕纳萨斯高地海伦-迪勒医疗中心(Helen Diller Medical Center at Parnassus Heights)2013 年 1 月 1 日至 2021 年 9 月 30 日期间急诊住院普通内科病人出院的所有成人患者:主要结果是:(1)住院病人平均每天接受的阿片类药物;(2)出院时开具的阿片类药物天数。对于这两项结果,我们首先进行了逻辑回归,以评估是否施用或开具阿片类药物的差异。然后,我们进行了负二项回归,以评估阿片类药物用量的差异。我们还对疼痛相关诊断的住院病人分组进行了所有分析:我们的研究队列包括 48,745 次住院治疗,涉及 27,777 名患者。其中,24,398 例(50.1%)住院患者为女性,24,347 例(49.9%)住院患者为男性。在控制了人口统计学、临床和住院层面的变量后,与男性患者相比,女性患者接受住院阿片类药物的可能性较低(调整后 OR 为 0.87;95% CI 为 0.82,0.92),平均每天接受的吗啡毫克当量减少 27.5(95% CI - 39.0,- 16.0)。在考虑出院阿片类药物时,没有发现性别间的显著差异。在疼痛相关诊断的分组分析中,女性患者住院时接受的阿片类药物较少:结论:女性患者接受住院阿片类药物治疗的可能性较低,开出的阿片类药物也较少。未来促进公平的工作应确定策略,确保所有患者都能得到适当的疼痛治疗。
{"title":"Sex Disparities in Opioid Prescription and Administration on a Hospital Medicine Service.","authors":"Nancy Yang, Margaret C Fang, Aksharananda Rambachan","doi":"10.1007/s11606-024-08814-7","DOIUrl":"10.1007/s11606-024-08814-7","url":null,"abstract":"<p><strong>Introduction: </strong>Decisions to prescribe opioids to patients depend on many factors, including illness severity, pain assessment, and patient age, race, ethnicity, and gender. Gender and sex disparities have been documented in many healthcare settings, but are understudied in inpatient general medicine hospital settings.</p><p><strong>Objective: </strong>We assessed for differences in opioid administration and prescription patterns by legal sex in adult patient hospitalizations from the general medicine service at a large urban academic center.</p><p><strong>Designs, setting, and participants: </strong>This study included all adult patient hospitalizations discharged from the acute care inpatient general medicine services at the University of California, San Francisco (UCSF) Helen Diller Medical Center at Parnassus Heights from 1/1/2013 to 9/30/2021.</p><p><strong>Main outcome and measures: </strong>The primary outcomes were (1) average daily inpatient opioids received and (2) days of opioids prescribed on discharge. For both outcomes, we first performed logistic regression to assess differences in whether or not any opioids were administered or prescribed. Then, we performed negative binomial regression to assess differences in the amount of opioids given. We also performed all analyses on a subgroup of hospitalizations with pain-related diagnoses.</p><p><strong>Results: </strong>Our study cohort included 48,745 hospitalizations involving 27,777 patients. Of these, 24,398 (50.1%) hospitalizations were female patients and 24,347 (49.9%) were male. Controlling for demographic, clinical, and hospitalization-level variables, female patients were less likely to receive inpatient opioids compared to male patents (adjusted OR 0.87; 95% CI 0.82, 0.92) and received 27.5 fewer morphine milligram equivalents per day on average (95% CI - 39.0, - 16.0). When considering discharge opioids, no significant differences were found between sexes. In the subgroup analysis of pain-related diagnoses, female patients received fewer inpatient opioids.</p><p><strong>Conclusions: </strong>Female patients were less likely to receive inpatient opioids and received fewer opioids when prescribed. Future work to promote equity should identify strategies to ensure all patients receive adequate pain management.</p>","PeriodicalId":15860,"journal":{"name":"Journal of General Internal Medicine","volume":" ","pages":"2679-2688"},"PeriodicalIF":4.3,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11535141/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141906799","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of General Internal Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1